OST-122

· Oncostellae S.L

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OST-122, covering 2023-01-13 to 2023-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis [Phase 1, Phase 2]